Stock Analysts’ updated eps estimates for Thursday, September 22nd:

Alexion Pharmaceuticals (NASDAQ:ALXN) had its buy rating reaffirmed by analysts at Cowen and Company.

Applied Materials (NASDAQ:AMAT) had its buy rating reissued by analysts at Pacific Crest.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/stock-analysts-updated-eps-estimates-for-september-22nd-alxn-amat-amzn-bam-a-banc-bayn-bbby-blue-cat-catm.html

Applied Materials (NASDAQ:AMAT) had its buy rating reiterated by analysts at Nomura. The firm currently has a $31.00 target price on the stock.

Amazon.com (NASDAQ:AMZN) had its buy rating reiterated by analysts at BMO Capital Markets.

Brookfield Asset Management (TSE:BAM.A) was upgraded by analysts at Royal Bank Of Canada from an outperform rating to a top pick rating. They currently have C$52.00 price target on the stock.

Banc of California (NYSE:BANC) had its hold rating reiterated by analysts at FBR & Co.

Bayer AG (FRA:BAYN) had its neutral rating reaffirmed by analysts at DZ Bank AG.

Bed Bath & Beyond (NASDAQ:BBBY) had its neutral rating reiterated by analysts at Credit Suisse Group AG. The firm currently has a $39.00 target price on the stock, down from their previous target price of $41.00.

Roth Capital began coverage on shares of Bluebird Bio (NASDAQ:BLUE). The firm issued a buy rating and a $87.00 target price on the stock.

Caterpillar (NYSE:CAT) had its buy rating reiterated by analysts at Credit Suisse Group AG.

Feltl & Co. assumed coverage on shares of Cardtronics (NASDAQ:CATM). Feltl & Co. issued a buy rating and a $48.00 target price on the stock.

China Mobile (NYSE:CHl) was downgraded by analysts at Goldman Sachs Group Inc. from a buy rating to a neutral rating.

Capital One Financial Corp. (NYSE:COF) had its hold rating reissued by analysts at Nomura. The firm currently has a $72.00 target price on the stock.

Columbia Sportswear (NASDAQ:COLM) had its hold rating reissued by analysts at Brean Capital.

Compass Point started coverage on shares of Outerwall (NASDAQ:CSTR). Compass Point issued a buy rating on the stock.

Carriage Services (NYSE:CSV) had its price target boosted by Barrington Research from $30.00 to $32.00. The firm currently has an outperform rating on the stock.

Cooper Tire & Rubber Co. (NYSE:CTB) had its buy rating reissued by analysts at FBR & Co. FBR & Co currently has a $48.00 target price on the stock. The analysts wrote, “We recently traveled with Cooper Tire & Rubber and are providing investors with four key takeaways that we believe continue to frame our investment thesis and answer some of the debate around CTB shares. With the DOC’s announcement of preliminary tariff levels on Chinese-made TBR tires, a critical debate that we think was a sticking point for some investors is now behind us. Fundamentals like pricing and volume are back in the spotlight, and in both cases Cooper seems well positioned. A slow climb in raw material pricing could flow down to consumers, and Cooper’s healthy new business pipeline in the OE market could present an opportunity to outpace the low-single-digit industry growth. Additionally, we believe that Cooper’s investments into rubber derived from the U.S.-grown guayule plant offer input cost savings over the long term that are not well-known.””

Dhx Media Ltd Class B (TSE:DHX.B) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a C$10.00 price target on the stock.

Dick’s Sporting Goods (NYSE:DKS) had its buy rating reiterated by analysts at Brean Capital.

Drax Group PLC (OTCMKTS:DRXGY) was downgraded by analysts at Jefferies Group from a hold rating to an underperform rating.

Fifth Third Bancorp (NASDAQ:FITB) was upgraded by analysts at Compass Point from a neutral rating to a buy rating.

General Mills (NYSE:GIS) had its hold rating reissued by analysts at Credit Suisse Group AG. They currently have a $68.00 target price on the stock.

General Mills (NYSE:GIS) had its hold rating reiterated by analysts at BMO Capital Markets. They currently have a $74.00 price target on the stock.

Glencore International PLC, St. Helier (NASDAQ:GLNCY) was upgraded by analysts at Liberum Capital from a sell rating to a hold rating.

Hibbett Sports (NASDAQ:HIBB) had its sell rating reissued by analysts at Brean Capital.

Intercept Pharmaceuticals (NASDAQ:ICPT) had its buy rating reiterated by analysts at Credit Suisse Group AG.

Imperial Oil Limited (TSE:IMO) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a C$47.00 price target on the stock.

LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at Sidoti from a buy rating to a neutral rating.

Nike (NYSE:NKE) had its buy rating reaffirmed by analysts at Brean Capital.

PepsiCo (NYSE:PEP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Soft CSD volumes is a pressing concern for Pepsi. Further, growing health awareness is hurting the CSD category, resulting in a 3% volume decline in the first half of 2016. Again, rising volatility in global markets and increasing currency headwind may dampen growth, going forward. That said, Pepsi has been doing well on the back of significant innovation, continued momentum in Frito-Lay business, revenue management strategies, improved productivity and better market execution. Moreover, Pepsi has been seeing higher volumes and profits in the North American segments due to an improving economy, better industry pricing dynamics and a consistency in positive innovation. We believe that Pepsi’ new product lineup, aggressive marketing efforts, productivity improvement and cost-saving initiatives should drive profits. Pepsi has rolled out several new products recently which management believes should drive sales and profits in the second half.”

Perry Ellis International (NASDAQ:PERY) had its buy rating reissued by analysts at Brean Capital.

PVH Corp. (NYSE:PVH) had its buy rating reissued by analysts at Brean Capital.

RPC (NYSE:RES) had its hold rating reissued by analysts at Nomura. The firm currently has a $14.00 target price on the stock.

Red Hat (NYSE:RHT) had its buy rating reiterated by analysts at Barclays PLC. The analysts wrote, “We continue to like the long- term story and believe the shares look attractive on a cash flow basis. Billings Growth and Large Deals Strong, App Dev Could Have Been Better: Billings grew 20% y/y this quarter, the strongest growth since 4Q14. We believe short term billings grew 17%, despite the longer duration, which is quite healthy. Deals over $1mn were up 60% y/y, underscoring Red Hat’s continued expansion with customers.””

J M Smucker (NYSE:SJM) was upgraded by analysts at Hilliard Lyons from an underperform rating to a neutral rating.

Synchrony Financial (NYSE:SYF) had its buy rating reaffirmed by analysts at Nomura. They currently have a $34.00 target price on the stock.

Syros Pharmaceuticals (NASDAQ:SYRS) had its buy rating reissued by analysts at Piper Jaffray Cos.. Piper Jaffray Cos. currently has a $20.00 price target on the stock.

T2 Biosystems (NASDAQ:TTOO) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $9.00 price target on the stock.

Under Armour (NYSE:UA) had its hold rating reaffirmed by analysts at Brean Capital.

Goldman Sachs Group Inc. started coverage on shares of Domtar Corp (TSE:UFS). The firm issued a neutral rating on the stock.

Viacom (NASDAQ:VIAB) had its buy rating reaffirmed by analysts at FBR & Co.

Viacom (NASDAQ:VIAB) had its buy rating reiterated by analysts at Brean Capital. They currently have a $44.00 price target on the stock.

Receive News & Ratings for Alexion Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alexion Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.